doi: 10.7501/j.issn.0253-2670.2025.12.014
Objective To study the therapeutic efficacy of Huoxue Zhitong Capsule (活血止痛胶囊, HXZT) on osteoarthritis (OA) rats. Methods The model of rats with OA was induced by improved Hulth method. After modeling, the rats were randomly divided into model group, Panlongqi Tablet (PL, 283 mg/kg) group, celecoxib (CEL, 18 mg/kg) group, HXZT low-, medium- and high-dose (135, 270, 540 mg/kg) groups, with 10 rats in each group, and 10 normal rats were selected as the control group. After 30 d of drug intervention, the pharmacodynamic effect of HXZT on OA rats was evaluated from the pain threshold, gait behavior, bone microstructure, knee joint pathology, oxidative stress level, inflammatory factor level and expressions of related functional proteins. Results Compared with model group, the mechanical reflex threshold of rats in HXZT group was significantly increased (P < 0.001), the length of footprints, the width of toes and the area of footprints were significantly decreased (P < 0.05, 0.01, 0.001), the number of trabecular bones, bone volume fraction, anisotropy and bone mineral density of knee joints were significantly increased (P < 0.01, 0.001), and the trabecular separation and structural model index were significantly decreased (P < 0.05, 0.01). The activity of lactate dehydrogenase (LDH) and the level of malondialdehyde (MDA) in serum and articular cartilage tissues were significantly decreased (P < 0.05, 0.01, 0.001), and the level of glutathione (GSH) and the activity of superoxide dismutase (SOD) were significantly increased (P < 0.05, 0.01, 0.001). The levels of interleukin-1β (IL-1β), IL-6, tumor necrosis factor-α (TNF-α), prostaglandin E2 (PGE2) and inducible nitric oxide synthase (iNOS) in serum and joint lavage fluid of rats were significantly decreased (P < 0.05, 0.01, 0.001). The protein expression levels of collagen II and tissue inhibitor of metal protease-1 (TIMP-1) in cartilage tissue were significantly increased (P < 0.001), while matrix metalloproteinases 13 (MMP13) and a disintegrin and metalloproteinase with thrombospondin motifs 5 (ADAMTS5) were significantly reduced (P < 0.001). Cartilage injury and degeneration and synovial inflammation were improved to varying degrees in rats. Conclusion HXZT can play a role in the treatment of OA by improving pain threshold, gait behavior, alterations in joint bone microstructure, cartilage damage, antioxidant factors, anti-inflammatory factors and expressions of functional proteins in OA rats.